Paul Damon & Associates, Inc. Merck & Co., Inc. Transaction History
Paul Damon & Associates, Inc.
- $147 Billion
- Q2 2024
A detailed history of Paul Damon & Associates, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Paul Damon & Associates, Inc. holds 2,063 shares of MRK stock, worth $210,157. This represents 0.17% of its overall portfolio holdings.
Number of Shares
2,063
Previous 2,007
2.79%
Holding current value
$210,157
Previous $265 Million
3.59%
% of portfolio
0.17%
Previous 0.18%
Shares
3 transactions
Others Institutions Holding MRK
# of Institutions
3,805Shares Held
1.92BCall Options Held
13.4MPut Options Held
10.6M-
Vanguard Group Inc Valley Forge, PA245MShares$24.9 Billion0.59% of portfolio
-
Black Rock Inc. New York, NY207MShares$21.1 Billion0.59% of portfolio
-
State Street Corp Boston, MA117MShares$12 Billion0.65% of portfolio
-
Wellington Management Group LLP Boston, MA72.5MShares$7.38 Billion1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA57MShares$5.81 Billion0.63% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $258B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...